miR1915 is a Serum Biomarker That Identifies Adult Acute Myeloid Leukaemia Patients with Poor Risk
Year: 2026
Type: dissertation
Study design: Observational Study
Abstract: MicroRNAs (miRNAs) are small, non-coding RNAs that are highly conserved and endogenous. In recent years their importance as regulators of gene expression in health and disease has been increasingly recognized, providing a new class of biomarkers readily available in body fluids. Acute myeloid leukaemia (AML) is a rare, heterogenous and refractory disease. To determine whether miRNAs could act as biomarkers for patients with AML, we examined miRNA expression in cells and patient serum. Previous investigators identified miRNAs that were differentially expressed between risk subgroups of AML patients using The Cancer Genome Atlas (TCGA) and analysed the pathways they acted on using DAVID. These were miR-486-1, miR-1915 and miR-8086. In this study, we examined which genes the DEmiRs target (miRTarBase) and examined which of these genes were associated with leukaemia (DisGeNet) and manually screened those to identify which were involved in AML. The pathways in which these genes are implicated were determined using DAVID and PANTHER.We further confirmed the expression of the most promising miRNAs in AML cells from patients at disease diagnosis using Xenabrowser, to examine RNA-sequencing data in the TCGA database. Four miRNAs (miR-4740, miR-4537, miR-4539 and miR-6772) were associated with AML (had a known role in disease pathogenesis). miR4740 was chosen because it was associated with the largest number of genes, a number of which have only recently been described in AML. The potential of these miRNAs to act as serum biomarkers of risk subgroups were analysed using qPCR. In addition, we examined miR-486-1, miR-1915 and miR8086 levels in serum samples based on previous data from our group. Serum expression between poor (n=18) and intermediate (n=14) risk subgroups was only statistically significant for miRNA-1915 (p=<0.001), for which Receiver Operator Characteristic analysis returned an Area Under the Curve (AUC) of 0.97 (95%CI=0.89-1). Future work should focus on the sensitivity and specificity of miR-1915 as a biomarker for disease risk in AML in a larger cohort of patient samples.
Author: Fletcher, Daniel
Institution: University of Hull
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7203525257
